Stablix, Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Stablix, Inc. is a biotechnology research company pursuing a new therapeutic strategy centered on targeted deubiquitination. The approach seeks to develop a small-molecule modality capable of stabilizing selected proteins to address diseases with unmet medical needs. Based in New York City and Boston, the company brings together a multidisciplinary team of scientists and leaders. The company engages in collaborations with other pharmaceutical and biotech organizations, as demonstrated by a strategic collaboration and license with Vertex Pharmaceuticals announced in April 2023. That agreement aims to discover and develop RESTORAC small molecules for targeted protein stabilization.